Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_3

60%

Ph phase_2

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

2(40.0%)

Phase 3Large-scale testing

3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Other(1)

Detailed Status

Completed3

unknown1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 3

Trials by Phase

Phase 22 (40.0%)

Phase 33 (60.0%)

Trials by Status

unknown120%

completed360%

terminated120%

Recent Activity

0 active trials

Showing 5 of 5

terminatedphase_2

A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

NCT00597649

unknownphase_2

Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes

NCT00553592

completedphase_3

Clinical Trials (5)

Showing 5 of 5 trials

NCT00597649Phase 2

A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Terminated

NCT00553592Phase 2

Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes

Unknown

NCT00281645Phase 3

Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain

Completed

NCT00295724Phase 3

Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain

Completed

NCT00295711Phase 3

Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5